Riskpilot← Back to searchSign inGet full accessBioLamina AB
ABActiveOrg 5567641872Löfströms Allé 5Research and experimental development on natural sciences and engineering · NACE 7210Est. 2008100-199 employees
Revenue 2024
SEK 237,1M
+37% vs 2023
EBITDA margin
10.2%
+57% vs 2023
Equity ratio
60.3%
Financial strength
Net profit 2024
SEK 11,6M
+55% vs 2023
| Revenue | SEK 237,1M | +37% |
| EBITDA | SEK 24,3M | +57% |
| Net profit | SEK 11,6M | +55% |
| Total assets | SEK 177,1M | +25% |
| Equity | SEK 106,8M | +11% |
| Employees | — | — |
Legal name
BioLamina AB
Org number
5567641872
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
22 augusti 2008
Share capital
SEK 232 000
Employees
100-199
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolagets verksamhet ska var att bedriva forskning, utveckling, produktion och försäljning inom biomedicin och bioteknik därmed förenlig verksamhet.
Address
Löfströms Allé 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 25 964 | 28 870 | 42 765 | 72 525 | 131 547 | 173 420 | 237 100 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −4 131 | −4 400 | 18 677 | 883 | −2 325 | 4 711 | 51 | 4 300 | 15 486 | 24 271 |
| Depreciation & amort. | −1 159 | −1 124 | −1 226 | −1 250 | −2 028 | −2 636 | −2 955 | −4 922 | −6 880 | −9 204 |
| EBIT | −5 290 | −5 524 | 17 451 | −367 | −4 353 | 2 075 | −2 904 | −622 | 8 606 | 15 067 |
| Net financials | −160 | 986 | −577 | 1 122 | 585 | −2 264 | 1 870 | 5 317 | 925 | −167 |
| Profit before tax | −5 451 | −4 538 | 16 875 | 754 | −3 768 | 943 | −1 033 | 4 695 | 9 531 | 14 901 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | 4 099 | −2 026 | −3 263 |
| Net profit | −5 451 | −4 538 | 16 875 | 754 | −3 768 | 943 | −1 033 | 8 794 | 7 505 | 11 638 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 25 167 | 21 842 | 38 285 | 43 558 | 39 505 | 65 735 | 104 168 | 134 932 | 141 564 | 177 131 |
| Equity | 22 903 | 18 365 | 35 240 | 37 462 | 33 694 | 58 782 | 78 304 | 87 835 | 95 924 | 106 816 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 6 816 | 6 152 | 0 | 26 625 |
| Short-term debt | 2 264 | 3 477 | 3 045 | 6 096 | 5 811 | 6 953 | 19 048 | 40 946 | 45 640 | 43 690 |
| Total debt | 2 264 | 3 477 | 3 045 | 6 096 | 5 811 | 6 953 | 25 864 | 47 098 | 45 640 | 70 315 |
EBITDA margin
10.2%
This company
15.8%
Market median
-35% vs market
20152024
Equity ratio
60.3%
This company
38.2%
Market median
+58% vs market
20152024
Return on equity
10.9%
This company
18.4%
Market median
+41% vs market
20152024
Net profit margin
4.9%
This company
8.1%
Market median
-40% vs market
20152024
Asset turnover
1.34×
This company
1.12×
Market median
+20% vs market
20152024
Debt / equity
0.66×
This company
0.62×
Market median
+6% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MG Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
JV Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
PA Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
CR Chief Auditor | Chief Auditor | 2023 | — | — |
CC Chief Auditor | Chief Auditor | 2020 | — | — |
KR Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2021 | — | — | |
| Chairman | 2020 | — | — | |
| Deputy Board Member | 2024 | — | — | |
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2023 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2022 | — | — | |
| Deputy Board Member | 2021 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Bure Growth AB | Company | 51.0% | 51.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Bure Equity AB
BioLamina AB Board members of BioLamina AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magnus Gustaf Samuel Åkerhielm | Chief Executive Officer | 0 companies |
| Jenny Veronica Byfield Sköld | Chief Executive Officer | 0 companies |
| Per Anders Lindblad | Chief Executive Officer | 0 companies |
| Claes Rutger Bo Nordström | Chief Auditor | 0 companies |
| Charlotte Catrine Holmstrand | Chief Auditor | 0 companies |
| Klaus Rudolf Langhoff-Roos | Chief Executive Officer | 0 companies |
| Anna Malm Bernsten | Board of Directors | 0 companies |
| Sophie Ingrid Madeleine Hagströmer | Chairman | 0 companies |
| Ingrid Charlotta Ljungqvist | Board of Directors | 0 companies |
| Magnus Per George Kenneby | Board of Directors | 0 companies |
| Per Jonas Pålsson | Board of Directors | 0 companies |
| Hans Fredrik Mattsson | Chairman | 0 companies |
| Max Ambjörn Jonson | Deputy Board Member | 0 companies |
| Maris Gunars Normunds Hartmanis | Board of Directors | 0 companies |
| Victor Decrion | Deputy Board Member | 0 companies |
| Stephanie K S M A Tigerschiöld | Board of Directors | 0 companies |
| Lewis Alexander Slack | Board of Directors | 0 companies |
| Karl Kristian Tryggvason | Board of Directors | 0 companies |
| John David Wennerström | Deputy Board Member | 0 companies |
| Karin Catarina Elisabet Flyborg | Board of Directors | 0 companies |
| Anne Camilla Huse Bondesson | Board of Directors | 0 companies |